Literature DB >> 22461519

Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice.

Yinghui Li1, Parag Kundu, Shih Wee Seow, Cristina Teixeira de Matos, Linda Aronsson, Keh Chuang Chin, Klas Kärre, Sven Pettersson, Gediminas Greicius.   

Abstract

Chronic inflammation is increasingly recognized as a major contributor of human colorectal cancer (CRC). While gut microbiota can trigger inflammation in the intestinal tract, the precise signaling pathways through which host cells respond to inflammatory bacterial stimulation are unclear. Here, we show that gut microbiota enhances intestinal tumor load in the APC(Min/+) mouse model of CRC. Furthermore, systemic anemia occurs coincident with rapid tumor growth, suggesting a role for intestinal barrier damage and erythropoiesis-stimulating mitogens. Short-term stimulation assays of murine colonic tumor cells reveal that lipopolysaccharide, a microbial cell wall component, can accelerate cell growth via a c-Jun/JNK activation pathway. Colonic tumors are also infiltrated by CD11b+ myeloid cells expressing high levels of phospho-STAT3 (p-Tyr705). Our results implicate the role of gut microbiota, through triggering the c-Jun/JNK and STAT3 signaling pathways in combination with anemia, in the acceleration of tumor growth in APC(Min/+) mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461519     DOI: 10.1093/carcin/bgs137

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  89 in total

1.  Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.

Authors:  Xiaowei Chen; Yoshihiro Takemoto; Huan Deng; Moritz Middelhoff; Richard A Friedman; Timothy H Chu; Michael J Churchill; Yan Ma; Karan K Nagar; Yagnesh H Tailor; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

Review 2.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

Review 3.  Gastrointestinal malignancy and the microbiome.

Authors:  Maria T Abreu; Richard M Peek
Journal:  Gastroenterology       Date:  2014-01-07       Impact factor: 22.682

Review 4.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

5.  'Hygienic' lymphocytes convey increased cancer risk.

Authors:  Tatiana Levkovich; Theofilos Poutahidis; Kelsey Cappelle; Mark B Smith; Allison Perrotta; Eric J Alm; Susan E Erdman
Journal:  J Anal Oncol       Date:  2014-08-12

6.  Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.

Authors:  Daniel Triner; Samantha N Devenport; Sadeesh K Ramakrishnan; Xiaoya Ma; Ryan A Frieler; Joel K Greenson; Naohiro Inohara; Gabriel Nunez; Justin A Colacino; Richard M Mortensen; Yatrik M Shah
Journal:  Gastroenterology       Date:  2018-12-11       Impact factor: 22.682

Review 7.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

8.  Colorectal cancer: looking for answers in the microbiota.

Authors:  Christian Jobin
Journal:  Cancer Discov       Date:  2013-04       Impact factor: 39.397

Review 9.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

Review 10.  Manipulating the Gut Microbiota: Methods and Challenges.

Authors:  Aaron C Ericsson; Craig L Franklin
Journal:  ILAR J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.